Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Archivos De La Sociedad Espanola De Oftalmologia|February 21, 2012
[Visual fields defect as inicial presentation of neurosarcoidosis]M L Maldonado-Morales, A Ruiz-Calvo, E Santos-Bueso, et al.
Archivos De La Sociedad Espanola De Oftalmologia|June 4, 2013
[Corneal chrysiasis. Gold salt deposits in the cornea in a patient with rheumatoid arthritis. An analysis with confocal microscopy]E Santos-Bueso, M Ahmed-Wasfy, F Sáenz-Francés, et al.
Transboundary and Emerging Diseases|June 9, 2011
Outbreak of swine erysipelas in a semi-intensive wild boar farm in SpainD Risco, P F Llario, R Velarde, et al.
Archivos De La Sociedad Espanola De Oftalmologia|November 27, 2021
Aniridia and the ocular surface: Medical and surgical problems and solutionsJ Álvarez de Toledo Elizalde, S López García, J M Benítez Del Castillo, et al.
Anales Espanoles De Pediatria|October 1, 1993
[Vitreous fluorophotometry and nocturnal GH secretion in young insulin-dependent diabetics treated with oral pirenzepine]J L Ruibal Francisco, J M Benítez del Castillo, G Seara Aguilar, et al.
Archivos De La Sociedad Espanola De Oftalmologia|July 1, 2020
Effects and safety of perfluorohexyloctane on the eye surface and corneal endotheliumA J Mateo Orobia, A Blasco-Martinez, P Rodríguez-Ausín, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|April 1, 1996
[Disparity between cytohistopathological results of diagnostic specimens and the resected tumor piece in bronchopulmonary carcinoma]J M Sánchez Varilla, J M Benítez Moya, M Baena Luna, et al.
International Journal of Pharmaceutics|June 25, 2022
Development of an osmoprotective microemulsion as a therapeutic platform for ocular surface protectionJ J López-Cano, M A González-Cela-Casamayor, V Andrés-Guerrero, et al.
The Ocular Surface|June 9, 2023
New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprostJ J López-Cano, M A González-Cela-Casamayor, V Andrés-Guerrero, et al.
The American Journal of Gastroenterology|May 15, 2019
Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic CancersMíriam Mañosa, M Chaparro, A Juan, et al.
Pageof 9